Page 1

Expressed at the plasma membrane. J Alzheimers Dis. 2009, 18 (4) :919-33. PubMed PMID: 19749435.

2: Cornejo-Cortes MA, Sanchez-Torres C, Vazquez-Chagoyán JC, Suarez-Gomez MH Garrido-Farina G, Meraz-Rios MA. Rat embryo quality and production efficiency are Dr. Marco Antonio Meraz Ríos

Cinvestav Researcher 3C National Research System: Level II PhD, Cell Biology (1990), CINVESTAV-IPN. Tel: +52 (55) 5747-3329 Fax: +52 (55) 5747-3938

Dose dependent on gonadotrophin in superovulatory treatments. Lab Anim. 2006 Jan, 40 (1) :87-95. PubMed PMID: 16460593.

3: Fields Aldrete ME, Salgado-Zamora H, Moon J, Melendez E, MerazRios MA. A high-throughput colorimetric and fluorometric microassay for the evaluation of Derivatives nitroimidazole anti-trichomonas activity. Toxicol In Vitro. 2005 Dec, 19 (8) :1045-50. Epub 2005 Jun 15. PubMed PMID: 15963680.

4: Meraz-Rios MA, Lira-De Leon KI, Campos-Pena V, De Anda-Hernandez MA, Research topics:

Molecular mechanisms involved in the genesis of Alzheimer’s.

Genetic susceptibility to Alzheimer’s disease.

R. Mena-Lopez Oligomers and tau aggregation in Alzheimer’s disease. J Neurochem. 2010 Mar, 112 (6) :1353-67. Epub 2009 Nov 27. Review. PubMed PMID: 19943854.

Representative publications: 1: Campos-Pena V, Tapia-Ramirez J, Sanchez-Torres C, Meraz-Rios MA.


Pathological-like assembly of tau induced by paired helical filament core to

Using computer models of neurodegeneration stereotactic induced toxic forms of β-amyloid 1-42

Centro de Investigación y de Estudios Avanzados del IPN

Tinción Argéntica amino-cúprico Born in Mexico City, D. F. in 1960. Pharmaceutical Chemistry Biologist’s degree from the Faculty of Higher-Cuautitlán the National Autonomous University of Mexico in 1983. He completed the Master of Science in Cell Biology Cinvestav of 1985-1987. He obtained his Ph.D. in Molecular Biology of CINVESTAV in l990. Postdoctoral studies conducted at Washington University School of Medicine, St. Louis, Missouri, USA from 1990 to 1995. He has taught undergraduate, master’s and doctoral degrees in Universities, Colleges and National Research Centers and abroad.

GFAP-DAPI for the Use and Care of Laboratory Animals, the Cinvestav. He has been Secretary for Planning, CINVESTAV. He was Director of Research CONACyT was Technical Secretary of the SEP-CONACYT Fund. Level 3C is Researcher, Department of Molecular Biomedicine. He has participated in forums of Science and Technology Policy of the Country, National and International. He has been Head of Delegation, representing Mexico at the Meeting of the Parties to the Cartagena Protocol in 2006. He served as Executive Secretary of the Interministerial Commission on Biosafety of Genetically Modified Organisms (CIBIOGEM) with level of Assistant Secretary of State appointment of the Executive Branch to coordinate the SEP, HEALTH, SAGARPA, SEMARNAT, ECONOMY, SHCP and CONACyT on Biosafety of GMOs.

He has also published 25 scientific articles in international magazines, with over 1700 citations to their work.

His research interests are: Molecular Biology of neurodegenerative diseases, Transgenic animal models and knock-outs of neurological diseases, Genomic Analysis and genomic susceptibility in the development of neurodegenerative diseases and the generation of new molecular markers in embryonic development and neronal.

Published 3 book chapters and several popular articles.


Has graduated 10 graduates, 23 Masters of Science and 11 PhDs.

He has given over 150 lectures at national and international forums, such as Australia, France, Spain, USA, Canada, Venezuela, Uruguay, Chile, Malaysia, Hawaii, Argentina, Vietnam, Costa Rica, Puerto Rico, Brazil and Colombia . It’s National Researcher Level II of the National System of Researchers. He has served as Academic Coordinator, Department of Cell Biology and Department of Molecular Biomedicine, was Coordinator of Bibliographic Services and Cinvestav Experimental and Chairman of the Institutional

Centro de Investigación y de Estudios Avanzados del IPN